How FDA currently makes decisions on clinical studies
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, these Bayesian methods are robust with small sample sizes (Irony & Simon, 2006; Lilford, Thornton, & Braunholtz, 1995; Temple, 2005).”
From Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial (2019) · cites this paper as Temple, 2005
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
(2001) · The Lancet · doi:10.1016/s0140-6736(00)04560-8 · Cited by 1,837 · cited 1×
“A new study called CAPRICORN studied post-infarction patients with left ventricular dysfunction (ejection fraction less than 40) [4].”
BackgroundEffect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661 · cited 1×
“Carvedilol was unequivocally effective in congestive heart failure; pooled early heart failure trials showed a survival effect for carvedilol and a large study in moderate to severe heart failure (COPERNICUS) showed a clear survival effect [5].”
Background
Cited by
Varadhan, R., Segal, J. B., Boyd, C. M., Wu, A. W., & Weiss, C. O. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.009 · Cited by 146
“Interestingly, this post hoc finding resulted in the Food and Drug Administration (FDA) approving valsartan for heart failure patients who cannot tolerate ACE inhibitors [8].”
BackgroundYammine, L., Green, C. E., Kosten, T. R., de Dios, C., Suchting, R., Lane, S. D., Verrico, C. D., & Schmitz, J. M. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab066 · Cited by 124
Prosthetic Heart Valves: Objective Performance Criteria Versus Randomized Clinical Trial
Grunkemeier, G. L., Jin, R., & STARR, A. M. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.06.037 · Cited by 77
The Role of p -Values in Judging the Strength of Evidence and Realistic Replication Expectations
Gibson, E. W. (2020) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2020.1724560 · Cited by 87
Buckner, J. D., Zvolensky, M. J., Ecker, A. H., Schmidt, N. B., Lewis, E. M., Paulus, D. J., Lopez-Gamundi, P., Crapanzano, K. A., & Bakhshaie, J. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.10.014 · Cited by 55
“Additionally, these Bayesian methods are robust with small sample sizes (Irony & Simon, 2006; Lilford, Thornton, & Braunholtz, 1995; Temple, 2005).”
Method
Metadata
- Authors
- Temple, R.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Temple, Robert
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2005-08
- Volume
- 2
- Issue
- 4
- Pages
- 276-281
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W1984604854
- Cited by
- 31
- References
- 8
- Citations by year
- 2026: 3 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2013: 3 · 2012: 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Clinical Trials (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- regulatory approval, drug regulation, clinical trial oversight
- MeSH terms
- Valsartan, Carvedilol, Adult, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Carbazoles, Child, Clinical Trials as Topic, Diabetic Nephropathies, Heart Failure, Humans, Propanolamines, Tetrazoles, United States, United States Food and Drug Administration, Valine, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How FDA currently makes decisions on clinical studies. https://app.cochat.ai/papers/10.1191/1740774505cn097oa
- The paper
- Temple, R. (2005). How FDA currently makes decisions on clinical studies. Clinical Trials. https://doi.org/10.1191/1740774505cn097oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.